trial

Improving Cognition Via Exercise in Schizophrenia

NCTId NCT03270098
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 104 (actual)
Sponsored by Icahn School of Medicine at Mount Sinai
Primary completion 2023-01-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
104 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2018-04-26
Primary completion
2023-01-31
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Aerobic exerciseStretching and Toning Exercise

Sponsors

Icahn School of Medicine at Mount SinaiLead Sponsor
University of North Carolina, Chapel HillCollaborator
Stanford UniversityCollaborator
Augusta UniversityCollaborator
Columbia UniversityCollaborator
National Institute of Mental Health (NIMH)Collaborator

Investigators

2
David Kimhy, PhDPrincipal Investigator
T. Scott Stroup, MD, MPHPrincipal Investigator

Sites

4 total
Stanford, United StatesAugusta, United StatesNew York, United StatesChapel Hill, United States

Facts & assertions

4 sourced
Enrollment
104
Phase
NA
Primary Completion Date
2023-01-31
Status
COMPLETED
relationships
The graph out of here
drug
Aerobic exercise
drug
Stretching and Toning Exercise
drug
lead_sponsor
Icahn School of Medicine at Mount Sinai
company
collaborator
University of North Carolina, Chapel Hill
company
Stanford University
company
indication
Schizophrenia and Related Disorders
indication
Schizophrenia
indication
investigator
David Kimhy, PhD
person
T. Scott Stroup, MD, MPH
person